Tuesday, January 25, 2022

Anti-Coronavirus Drug Made in Iran, Currently in Clinical Procedures: Official

More Articles

Avatar of IFP Editorial Staff
IFP Editorial Staffhttps://ifpnews.com/ifp-editorial-staff
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.
Head of Iran’s Baqiyatallah University of Medical Sciences says one of the university’s research centres has managed to produce a drug for the novel coronavirus, and the medicine is currently undergoing clinical trials.

Alireza Jalali has told Fars News Agency that the research centre has received clinical trial authorisation from the Food and Drug Organization of Iran to begin the studies quickly.
Nearly 3,000 people have already been infected with the deadly virus across Iran and nearly 100 have lost their lives due to the outbreak so far.
Earlier, researchers at a knowledge-based company based in Iran’s Lorestan province had succeeded in developing coronavirus detection kit.
Ali Gholami, the CEO of the company, said “before the outbreak of Coronavirus in the country, and after its genome was put in the US database, the production of the kit started.”
He also added that the corona detection kit was designed and manufactured based on world-class standards.
“The scientists at the company have developed and synthesized a piece of the virus genome in a simulated manner. The kit responds very well,” noted Gholami.

Latest article